Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial. Rugo HS, Seneviratne…
Managing Expectations in the Transition to Proof of Concept Studies. Kieber-Emmons T, Makhoul I, Pennisi A, Siegel ER, Emanuel PD, Monzavi-Karbassi B, Steplewski Z, Beck…
The Role of Proteomic Testing in Improving Prognosis And Care Planning Quality Measures for Lung Cancer. Page RD, Argento AC, Nash DB, Skoufalos A, Schaefer…
nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy. Thomas M, Spigel DR, Jotte RM, McCleod M, Socinski MA, Page RD, Gressot…
Financial Conflicts of Interest Among Oncology Clinical Pathway Vendors Daly B, Bach PB, Page RD. JAMA Oncol. 2017 Dec 21. doi: 10.1001/jamaoncol.2017.4473. [Epub ahead of…
Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. BACKGROUND:The…
The VeriStrat 1 (VS) test is intended to help guide treatment decisions for patients with advanced non-small-cell lung cancer (NSCLC) without an EGFR-sensitizing mutation, classifying…
RECORD-3 compared everolimus and sunitinib as first-line therapy, and the sequence of everolimus followed by sunitinib at progression compared with the opposite (standard) sequence in…
Stomatitis is a class effect associated with the inhibition of mTOR and is associated with everolimus therapy for breast cancer. Topical steroids might reduce stomatitis…
Stomatitis is a class effect associated with the inhibition of mTOR and is associated with everolimus therapy for breast cancer. Topical steroids might reduce stomatitis…